Yubo International Biotech Limited (YBGJ)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | 790.49 Thousand USD | -70.66% |
| 2021 | 2.69 Million USD | 754.67% |
| 2020 | 315.2 Thousand USD | -75.47% |
| 2019 | 1.28 Million USD | 11.64% |
| 2018 | 1.15 Million USD | 23.1% |
| 2017 | 935 Thousand USD | 14.58% |
| 2016 | 816 Thousand USD | 17.75% |
| 2015 | 693 Thousand USD | 22.01% |
| 2014 | 568 Thousand USD | 19.33% |
| 2013 | 476 Thousand USD | 22.05% |
| 2012 | 390 Thousand USD | 25.4% |
| 2011 | 311 Thousand USD | 34.63% |
| 2010 | 231 Thousand USD | 46.2% |
| 2009 | 158 Thousand USD | 66.32% |
| 2008 | 95 Thousand USD | 150.0% |
| 2007 | 38 Thousand USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q2 | 560.6 Thousand USD | -15.96% |
| 2023 Q1 | 667.04 Thousand USD | -15.62% |
| 2022 Q1 | 2.77 Million USD | 2.92% |
| 2022 Q3 | 2.2 Million USD | -8.03% |
| 2022 FY | 790.49 Thousand USD | -70.66% |
| 2022 Q2 | 2.39 Million USD | -13.57% |
| 2022 Q4 | 790.49 Thousand USD | -64.13% |
| 2021 Q4 | 2.69 Million USD | 14.99% |
| 2021 Q3 | 2.34 Million USD | 14.23% |
| 2021 FY | 2.69 Million USD | 754.67% |
| 2021 Q1 | 1.94 Million USD | 516.21% |
| 2021 Q2 | 2.05 Million USD | 5.59% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q3 | 1.47 Million USD | 0.0% |
| 2020 FY | 315.2 Thousand USD | -75.47% |
| 2020 Q4 | 315.2 Thousand USD | -78.59% |
| 2020 Q1 | - USD | -100.0% |
| 2019 Q2 | 1.28 Million USD | 0.0% |
| 2019 Q1 | 1.28 Million USD | 2.64% |
| 2019 Q4 | 1.38 Million USD | 2.22% |
| 2019 FY | 1.28 Million USD | 11.64% |
| 2019 Q3 | 1.35 Million USD | 5.06% |
| 2018 Q4 | 1.25 Million USD | 2.37% |
| 2018 Q3 | 1.22 Million USD | 0.0% |
| 2018 Q2 | - USD | -100.0% |
| 2018 Q1 | 1.15 Million USD | 9.2% |
| 2018 FY | 1.15 Million USD | 23.1% |
| 2017 Q1 | 935 Thousand USD | 4.35% |
| 2017 FY | 935 Thousand USD | 14.58% |
| 2017 Q3 | 1.01 Million USD | 0.0% |
| 2017 Q4 | 1.05 Million USD | 3.43% |
| 2017 Q2 | - USD | -100.0% |
| 2016 Q1 | 816 Thousand USD | 4.21% |
| 2016 FY | 816 Thousand USD | 17.75% |
| 2016 Q4 | 896 Thousand USD | 2.05% |
| 2016 Q3 | 878 Thousand USD | 0.0% |
| 2016 Q2 | - USD | -100.0% |
| 2015 Q3 | - USD | -100.0% |
| 2015 FY | 693 Thousand USD | 22.01% |
| 2015 Q1 | 693 Thousand USD | 4.05% |
| 2015 Q4 | 783 Thousand USD | 0.0% |
| 2015 Q2 | 693 Thousand USD | 0.0% |
| 2014 Q1 | 568 Thousand USD | 2.34% |
| 2014 Q3 | 627 Thousand USD | 10.39% |
| 2014 FY | 568 Thousand USD | 19.33% |
| 2014 Q2 | 568 Thousand USD | 0.0% |
| 2014 Q4 | 666 Thousand USD | 6.22% |
| 2013 Q1 | 476 Thousand USD | 6.73% |
| 2013 Q4 | 555 Thousand USD | 0.0% |
| 2013 FY | 476 Thousand USD | 22.05% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | -100.0% |
| 2012 Q1 | 390 Thousand USD | 7.44% |
| 2012 Q2 | 390 Thousand USD | 0.0% |
| 2012 Q3 | 435 Thousand USD | 11.54% |
| 2012 Q4 | 446 Thousand USD | 2.53% |
| 2012 FY | 390 Thousand USD | 25.4% |
| 2011 FY | 311 Thousand USD | 34.63% |
| 2011 Q2 | 311 Thousand USD | 0.0% |
| 2011 Q3 | 354 Thousand USD | 13.83% |
| 2011 Q4 | 363 Thousand USD | 2.54% |
| 2011 Q1 | 311 Thousand USD | 8.36% |
| 2010 Q3 | 270 Thousand USD | 16.88% |
| 2010 FY | 231 Thousand USD | 46.2% |
| 2010 Q4 | 287 Thousand USD | 6.3% |
| 2010 Q1 | 231 Thousand USD | 0.0% |
| 2010 Q2 | 231 Thousand USD | 0.0% |
| 2009 FY | 158 Thousand USD | 66.32% |
| 2009 Q1 | 158 Thousand USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 Q1 | 95 Thousand USD | 0.0% |
| 2008 FY | 95 Thousand USD | 150.0% |
| 2007 Q1 | 38 Thousand USD | 0.0% |
| 2007 FY | 38 Thousand USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 500 Thousand USD | -58.1% |
| Ansell Limited | 855.59 Million USD | 99.908% |
| Ansell Limited | 857.2 Million USD | 99.908% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | 96.473% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 20.93 Thousand USD | -3675.968% |
| Psykey, Inc. | 1.01 Million USD | 21.779% |
| ConvaTec Group Plc | 1.31 Billion USD | 99.94% |
| ConvaTec Group Plc | 1.31 Billion USD | 99.94% |
| Encision Inc. | 1.33 Million USD | 40.707% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 65.76% |
| Innovative MedTech Inc. | 1.87 Million USD | 57.912% |
| LifePoint, Inc. | 446.74 Thousand USD | -76.948% |
| Medite Cancer Diagnostics, Inc. | 5.39 Million USD | 85.345% |
| Paradigm Medical Industries, Inc. | 2.18 Million USD | 63.888% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 242.64 Thousand USD | -225.786% |
| SmileDirectClub, Inc. | 871.79 Million USD | 99.909% |
| Sector 10, Inc. | 164 Thousand USD | -382.012% |
| Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 99.883% |
| SheerVision, Inc. | 75 Thousand USD | -953.999% |
| United Health Products, Inc. | 755.98 Thousand USD | -4.565% |
| Vasamed, Inc. | 23.45 Thousand USD | -3270.998% |
| Wearable Health Solutions, Inc. | 2.76 Million USD | 71.435% |